Platelets

Megakaryocytes

All of these cellsThe basic structural and functional units of life. here derive from a myeloid stem cell. This cell over on the left called a megakaryocyte explodes into fragments each containing a piece of the nucleusThe control center of the cell that contains DNA and directs cellular activities.. These fragments are called platelets.   A single megakaryocyte can produce thousands of platelets before being destroyed or phagocytosed.

Platelets

Platelets are essential for clotting and last about 10 days. High platelet counts might indicate a recent event, even if it’s no longer ongoing. Blood clotting, or hemostasis, involves positive feedbackA control mechanism that amplifies a change instead of reversing it.. Platelets form a plug at a broken vessel site, attracting more platelets to create a temporary seal. This process has three stages: vascular spasm (like a tourniquet), platelet plug formation, and coagulation (blood clot formation). Fibrinogen, a soluble protein, becomes insoluble fibrinAn insoluble protein that forms the mesh of blood clots. during clotting. It forms a mesh that traps red blood cells to create a clot.

Coagulation involves a cascade of reactions ending in fibrin production. Factor X plays a central role, converting prothrombin to thrombin, which then converts fibrinogen plasma protein converted into fibrin during blood clotting. to fibrin. Hemophilia results from lacking proteinsLarge molecules made of amino acids with various functions in the body. necessary to activate Factor X. Blood thinners, like heparin and aspirin, prevent clotting by targeting thrombin, while plasmin breaks up existing clots.

Blood clots can block vessels, causing conditions like myocardial infarctions (heart attacks) or pulmonary embolisms. Coronary thrombosis blocks blood flow to heart tissues, causing tissue death. Pulmonary embolisms occur when clots block lung capillariesThe smallest blood vessels where gas, nutrient, and waste exchange occurs between blood and tissues., depriving the body of oxygen and potentially leading to brain damage.

Hemostasis

The primary difference between fibrinogen and fibrin lies in their role in blood clotting and their structural states. Fibrinogen is a soluble glycoproteinA protein with a carbohydrate chain attached, important for cell signaling.. It circulates in the blood plasmaThe liquid component of blood.. It serves as an inactive precursor for hemostasis, or stoppage of bleeding.  Like many plasma proteins, fibrinogen is made by the liverA large organ that produces bile, detoxifies blood, and stores nutrients..

Fibrin, on the other hand, is the active, insoluble protein formed when fibrinogen is cleaved by the enzyme thrombin. This cleavage allows fibers to weave together to create a stable clot. It serves as a blood band aid on a broken vessel.  This physical barrier prevents further blood loss and provides a scaffold for tissue repair.

Stages 1 and 2

When a blood vessel is injured, the smooth muscle in the vessel wall contracts in a vascular spasm.  This vasoconstrictionThe narrowing of blood vessels due to contraction of smooth muscle, increasing blood pressure and re reduces blood flow and limits blood loss at the site of injury. The vascular spasm is triggered by signals such as endothelin, a substance released by damaged endothelial cells. The spasm’s duration depends on the injury’s severity. It serves as the first line of defense. Meanwhile, the next stages are initiated.

In this stage, platelets adhere to the exposed collagenA structural protein in the dermis that provides strength and elasticity. fibers in the damaged vessel wall. This adhesionThe tendency of water molecules to stick to other substances. is mediated by von Willebrand factor, a protein that bridges platelets and collagen. Upon binding, platelets become activated, changing shape and releasing chemical signals such as thromboxane. These signals recruit and activate more platelets to the site, leading to platelet aggregation. The growing mass of platelets forms a temporary platelet plug. It is sufficient to stop bleeding in minor injuries. However, the plug is unstable without further stabilization.

Stage 3 Coagulation

The final step of hemostasis has its own substeps, and there are lots of them.  All of these steps are part of the coagulation cascade, a series of reactions that leads to a fibrin mesh.  Most steps of the cascade are simple enzymatic reactions where a substrate is changed into a product by an enzyme.  There are about 20 of these enzymesProteins that speed up chemical reactions in the body.. They have names such as clotting factor V, VI, VII, and so on.  All these clotting factors are made by the liver. 

Types of hemophilia, a bleeding disorder, are characterized by the lack of one of these enzymatic proteins.  The cascade has two pathways. The intrinsic pathway is initiated by damage within the vessel. The extrinsic pathway is triggered by tissue factor from damaged tissue. Both pathways converge at the activation of prothrombin into thrombin, a reaction catalyzed by Factor X. So, all pathways lead to factor X. Thrombin catalyzes the conversion of fibrinogen into fibrin. This fibrin mesh stabilizes the platelet plug. It creates a strong, durable clot to seal the injury site. The clot remains until the vessel can repair itself.

Anticoagulants

Anticoagulants are medications that help prevent the formation of blood clots or slow the growthAn increase in size and number of cells. of existing clots. They interfere with various steps in the blood clotting process. They either inhibit clotting factors or reduce the blood’s ability to coagulate. Anticoagulants are often prescribed to reduce the risk of serious conditions. These include deepAway from the surface of the body. vein thrombosis (DVT), pulmonary embolism (PE), stroke, and complications from atrial fibrillation (AFib) or mechanical heart valves.

Warfarin inhibits the production of vitamin K-dependent clotting factors (factors II, VII, IX, and X) in the liver. This reduces the blood’s clotting ability.
Apixaban inhibits Factor X, a crucial enzyme in the clotting cascade.